- Home
- FCUV vs NRXP Comparison
FCUV vs NRXP Comparison
Compare FCUV & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCUV
- NRXP
- Stock Information
- Founded
- FCUV 2012
- NRXP 2015
- Country
- FCUV United States
- NRXP United States
- Employees
- FCUV N/A
- NRXP N/A
- Industry
- FCUV Industrial Machinery/Components
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- FCUV Industrials
- NRXP Health Care
- Exchange
- FCUV Nasdaq
- NRXP Nasdaq
- Market Cap
- FCUV 27.6M
- NRXP 32.6M
- IPO Year
- FCUV N/A
- NRXP N/A
- Fundamental
- Price
- FCUV $3.67
- NRXP $3.01
- Analyst Decision
- FCUV
- NRXP Strong Buy
- Analyst Count
- FCUV 0
- NRXP 4
- Target Price
- FCUV N/A
- NRXP $28.50
- AVG Volume (30 Days)
- FCUV 14.5K
- NRXP 190.3K
- Earning Date
- FCUV 08-13-2025
- NRXP 08-13-2025
- Dividend Yield
- FCUV N/A
- NRXP N/A
- EPS Growth
- FCUV N/A
- NRXP N/A
- EPS
- FCUV N/A
- NRXP N/A
- Revenue
- FCUV $408,887.00
- NRXP N/A
- Revenue This Year
- FCUV N/A
- NRXP N/A
- Revenue Next Year
- FCUV N/A
- NRXP N/A
- P/E Ratio
- FCUV N/A
- NRXP N/A
- Revenue Growth
- FCUV 6.49
- NRXP N/A
- 52 Week Low
- FCUV $1.50
- NRXP $1.10
- 52 Week High
- FCUV $10.90
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- FCUV 37.02
- NRXP 42.90
- Support Level
- FCUV $3.73
- NRXP $3.12
- Resistance Level
- FCUV $4.05
- NRXP $3.53
- Average True Range (ATR)
- FCUV 0.22
- NRXP 0.18
- MACD
- FCUV -0.03
- NRXP -0.06
- Stochastic Oscillator
- FCUV 13.82
- NRXP 1.89
About FCUV Focus Universal Inc.
Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.